• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

42.46 -0.45 (-1.05%)
Streaming Delayed Price Updated: 9:43 AM EDT, Jul 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 309,552
Open 42.73
Bid (Size) 42.44 (400)
Ask (Size) 42.47 (500)
Prev. Close 42.91
Today's Range 42.42 - 43.03
52wk Range 22.73 - 43.91
Shares Outstanding 418,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Is CRSP Stock Falling Pre-Market Today? ↗
March 10, 2026
The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031. 
Via Stocktwits
News headline image
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
February 25, 2026
Recursion reported a loss of $0.21 per share on revenue of $35.5 million, compared to Wall Street estimates of a loss of $0.32 per share on revenue of $24.6 million, according to Koyfin. 
Via Stocktwits
Topics Artificial Intelligence

Performance

YTD
+45.5%
+45.5%
1 Month
+27.1%
+27.1%
3 Month
+55.8%
+55.8%
6 Month
+41.6%
+41.6%
1 Year
+74.4%
+74.4%

More News

Read More
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
February 17, 2026
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
February 17, 2026
Via Stocktwits
BEAM Stock In Focus As FDA Alignment Wins William Blair’s Praise ↗
January 12, 2026
Via Stocktwits
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
February 02, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
January 16, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
November 30, 2025
Via The Motley Fool
Topics ETFs
News headline image
Why Tempus AI Stock Soared This Week ↗
November 28, 2025
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
November 03, 2025
Via Benzinga
Topics ETFs
News headline image
Wellgistics Health's 200% Surge Puts AI-Pharma Tie-Ups On The ETF Map ↗
October 24, 2025
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗
October 22, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
October 17, 2025
Via Benzinga
Topics ETFs Government
News headline image
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗
October 10, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗
October 08, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI ↗
September 16, 2025
Via Benzinga
News headline image
Cathie Wood, Dan Ives Align On These 11 AI Stock Picks — Some Might Surprise You ↗
September 15, 2025
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock ↗
September 11, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost ↗
September 09, 2025
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers ↗
August 25, 2025
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade ↗
August 14, 2025
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion ↗
August 02, 2025
Via Benzinga
News headline image
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills ↗
July 26, 2025
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics ↗
July 26, 2025
Via Benzinga

Frequently Asked Questions

Is ARK Genomic Revolution ETF publicly traded?
Yes, ARK Genomic Revolution ETF is publicly traded.
What exchange does ARK Genomic Revolution ETF trade on?
ARK Genomic Revolution ETF trades on the New York Stock Exchange
What is the ticker symbol for ARK Genomic Revolution ETF?
The ticker symbol for ARK Genomic Revolution ETF is ARKG on the New York Stock Exchange
What is the current price of ARK Genomic Revolution ETF?
The current price of ARK Genomic Revolution ETF is 42.46
When was ARK Genomic Revolution ETF last traded?
The last trade of ARK Genomic Revolution ETF was at 07/06/26 09:43 AM ET
What is the market capitalization of ARK Genomic Revolution ETF?
The market capitalization of ARK Genomic Revolution ETF is 17.75M
How many shares of ARK Genomic Revolution ETF are outstanding?
ARK Genomic Revolution ETF has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap